Feldkamp J, Seppel T, Mühlmeyer M, Becker A, Santen R, Schlaghecke R, Horster F A
Klinik für Endokrinologie, Universität Düsseldorf.
Dtsch Med Wochenschr. 1996 Dec 20;121(51-52):1587-91. doi: 10.1055/s-2008-1043186.
To compare the efficacy of iodide (300 micrograms daily) with that of levothyroxine (1.5 micrograms/kg daily) in the treatment of endemic goitre in middle-aged and elderly persons. The possible occurrence of antibodies against thyroid peroxidase and thyroglobulin was also tested.
67 patients (54 women, 13 men; aged over 40 years, average 53.5 years) with endemic goitre, excluding toxic goitre, were randomly treated with either iodine or thyroxine. Every 3 months for one year their thyroid volume was obtained by ultrasound and the activities of thyroid hormone (TH) and thyroid stimulating hormone (TSH) and the concentration of antibodies against peroxidase and thyroglobulin were measured.
In patients on levothyroxine the thyroid volume had already markedly decreased after 3 months (P < 0.0001), diminishing by 15.4% at 12 months. Volume reduction in the group on iodine was 16.2% at one year. There was no significant difference between the two medications and no case of antibody production in the iodine group.
Treatment of endemic goitre with iodine alone is efficacious even in middle-aged or elderly patients, toxic goitre having been excluded. There was no evidence of antibody production against thyroid antigens at the stated iodine dosage.
比较碘化物(每日300微克)与左甲状腺素(每日1.5微克/千克)治疗中老年地方性甲状腺肿的疗效。同时检测甲状腺过氧化物酶和甲状腺球蛋白抗体的可能产生情况。
67例(54例女性,13例男性;年龄超过40岁,平均53.5岁)地方性甲状腺肿患者,排除毒性甲状腺肿,随机接受碘或甲状腺素治疗。在一年时间里,每3个月通过超声测量甲状腺体积,并检测甲状腺激素(TH)和促甲状腺激素(TSH)活性以及过氧化物酶和甲状腺球蛋白抗体浓度。
接受左甲状腺素治疗的患者在3个月后甲状腺体积已显著减小(P < 0.0001),12个月时减小了15.4%。碘治疗组一年时体积缩小16.2%。两种药物之间无显著差异,碘治疗组无抗体产生病例。
即使在中老年患者中,排除毒性甲状腺肿后,单独使用碘治疗地方性甲状腺肿是有效的。在规定的碘剂量下,没有证据表明会产生针对甲状腺抗原的抗体。